Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus

Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus

The 2013–2015 West African epidemic of Ebola virus disease (EVD) reminds us of how little is known about biosafety level 4 viruses. Like Ebola virus, Lassa virus (LASV) can cause hemorrhagic fever with high case fatality rates. We generated a genomic catalog of almost 200 LASV sequences from clinica...

Full description

Bibliographic Details
Main Author:	Sealfon, Rachel Sima
Other Authors:	Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Format:	Article
Language:	en_US
Published:	Elsevier 2017
Online Access:	http://hdl.handle.net/1721.1/106818

Similar Items

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
by: Sealfon, Rachel Sima, et al.
Published: (2015)

Computational investigation of pathogen evolution
by: Sealfon, Rachel (Rachel Sima)
Published: (2015)

Immunological screening of Lassa virus among health workers and contacts of patients of Lassa fever in Ondo State
by: Shaibu, JO, et al.
Published: (2021)

Predicting enhancer regions and transcription factor binding sites in D. melanogaster
by: Sealfon, Rachel (Rachel Sima)
Published: (2011)

Isolation of a cellular receptor for lymphocytic choriomeningitis virus and Lassa fever virus
by: Cao, W, et al.
Published: (1999)

Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus.
by: Cao, W, et al.
Published: (1998)

Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014
by: Sealfon, Rachel
Published: (2020)

Human antibody pieces together the puzzle of the trimeric Lassa virus surface antigen
by: Zeltina, A, et al.
Published: (2017)

Structure of the Lassa virus glycan shield provides a model for immunological resistance
by: Watanabe, Y, et al.
Published: (2018)

Metagenomic investigation of co-infections of Ebola virus disease and Lassa fever patients
by: Krasilnikova, Lydia A
Published: (2016)

Vaccine platforms for the prevention of Lassa fever
by: Purushotham, J, et al.
Published: (2019)

Uncovering 1058 novel human enteric DNA viruses through deep long-read third-generation sequencing and their clinical impact
by: Zhao, Liuyang, et al.
Published: (2022)

Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design
by: Merson, L, et al.
Published: (2021)

Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE)
by: Duvignaud, A, et al.
Published: (2020)

Acidic pH-Induced conformations and LAMP1 binding of the Lassa virus glycoprotein spike
by: Li, S, et al.
Published: (2016)

The origin and continuing adaptive evolution of chikungunya virus
by: Hakim, Mohamad S., et al.
Published: (2022)

The origin and continuing adaptive evolution of chikungunya virus
by: Hakim, Mohamad S., et al.
Published: (2022)

Risk maps of Lassa fever in West Africa.
by: Fichet-Calvet, E, et al.
Published: (2009)

Risk maps of Lassa fever in West Africa
by: Fichet-Calvet, E, et al.
Published: (2009)

Mapping the zoonotic niche of Lassa fever in Africa.
by: Mylne, A, et al.
Published: (2015)

Time to reconsider the role of ribavirin in Lassa fever
by: Salam, AP, et al.
Published: (2021)

Evaluation of the Potential Impact of Ebola Virus Genomic Drift on the Efficacy of Sequence-Based Candidate Therapeutics
by: Kugelman, Jeffrey R., et al.
Published: (2015)

A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever
by: Olayinka, AT, et al.
Published: (2022)

Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: a prospective hospital-based cohort study
by: Kayem, ND, et al.
Published: (2023)

The biosafety research road map: the search for evidence to support practices in the laboratory—Crimean Congo Haemorrhagic Fever virus and Lassa virus
by: Blacksell, SD, et al.
Published: (2023)

Lassa fever outbreak in Nigeria: How prepared are we?
by: Olatayo Adeoti, A, et al.
Published: (2018)

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse
by: Flaxman, A, et al.
Published: (2024)

Ribavarin for treating Lassa fever: a systematic review of pre-clinical studies and implications for human dosing
by: Salam, AP, et al.
Published: (2022)

Uncovering incontinentia pigmenti: From DNA sequence to pathophysiology
by: Kang, Nien How, et al.
Published: (2022)

Transcriptome and genome sequencing uncovers functional variation in humans.
by: Lappalainen, T, et al.
Published: (2013)

Transcriptome and genome sequencing uncovers functional variation in humans
by: Lappalainen, T, et al.
Published: (2013)

On the origins of birds: the sequence of character acquisition in the evolution of avian flight
by: Garner, J, et al.
Published: (1999)

A Cis-Regulatory Map of the Drosophila Genome
by: Bristow, Christopher A., et al.
Published: (2012)

Lassa fever in pregnancy: a systematic review and meta-analysis
by: Kayem, ND, et al.
Published: (2020)

Geographical drivers and climate-linked dynamics of Lassa fever in Nigeria
by: Redding, DW, et al.
Published: (2021)

Viral haemorrhagic fevers in pregnancy with a focus on lassa fever
by: Kayem, ND
Published: (2021)

Health and economic impacts of Lassa vaccination campaigns in West Africa
by: Smith, D, et al.
Published: (2024)

Uncovering online lifestyle segments using the Motivation Sequence Model
by: Ang, Yvonne Su Ming
Published: (2018)

Lassa fever susceptibility modelling and mapping in Nigeria using geospatial technique
by: Linda, Izah Ngozi
Published: (2023)

The origin and evolution of sex chromosomes, revealed by sequencing of the Silene latifolia female genome
by: Yue, J, et al.
Published: (2023)